ICD-11 · 6C42.1

Harmful pattern of use of synthetic cannabinoids

A pattern of use of synthetic cannabinoids that has caused damage to a person’s physical or mental health or has resulted in behavior leading to harm to the health of others. The pattern of synthetic cannabinoid use is evident over a period of at least 12 months if substance use is episodic or at least one month if use is continuous (i.e., daily or almost daily). Harm to health of the individual occurs due to one or more of the following: (1) behavior related to intoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) a harmful route of administration. Harm to health of others includes any form of physical harm, including trauma, or mental disorder that is directly attributable to behavior related to synthetic cannabinoid intoxication on the part of the person to whom the diagnosis of Harmful pattern of use of synthetic cannabinoids applies.

ICD-11 diagnostic criteria

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Harmful pattern of use of synthetic cannabinoids are:

Differential diagnosis

When diagnosing Harmful pattern of use of synthetic cannabinoids, the following ICD-11 disorders should be considered in the differential diagnosis:

Frequently asked questions

How is Harmful pattern of use of synthetic cannabinoids diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Harmful pattern of use of synthetic cannabinoids (6C42.1) include: powtarzające się używanie syntetycznych kannabinoidów; negatywne konsekwencje zdrowotne lub społeczne.

What disorders are in the differential diagnosis of Harmful pattern of use of synthetic cannabinoids?

The differential diagnosis of Harmful pattern of use of synthetic cannabinoids (6C42.1) includes: Epizod szkodliwego używania syntetycznych kannabinoidów (6C42.0), Uzależnienie od syntetycznych kannabinoidów (6C42.2), Uzależnienie od syntetycznych kannabinoidów, obecne używanie (6C42.20), Uzależnienie od syntetycznych kannabinoidów, wczesna pełna remisja (6C42.21), Uzależnienie od syntetycznych kannabinoidów, utrzymująca się częściowa remisja (6C42.22), Uzależnienie od syntetycznych kannabinoidów, utrzymująca się pełna remisja (6C42.23), Inne określone uzależnienie od syntetycznych kannabinoidów (6C42.2Y), Uzależnienie od syntetycznych kannabinoidów, nieokreślone (6C42.2Z).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C42.1 – WHO ICD-11

Open in interactive browser →
Source: WHO ICD-11 (chapter 6 – Mental, behavioral and neurodevelopmental disorders). Used under CC BY-ND 3.0 IGO. ICD Diagnostica is not affiliated with or endorsed by WHO. Informational use only – does not replace clinical judgment.